Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts

Area of Science:

• Regenerative Medicine
• Cardiology
• Stem Cell Biology

Background:

• Heart disease remains a major global health concern with limited predictive capabilities for heart failure.
• Current treatments fail to address cardiac tissue loss, necessitating innovative therapies beyond transplantation.
• The myocardium possesses self-renewal capacity, but it's often insufficient for recovery after infarction.

Purpose of the Study:

• To critically evaluate the use of four major stem cell types in treating heart disease.
• To assess preclinical and clinical studies on stem cell therapy for cardiac repair.
• To discuss current challenges and future directions in the field.

Main Methods:

• Review of preclinical and clinical studies on stem cell therapy for heart disease.
• Focus on induced pluripotent stem cells (iPSC), embryonic stem cells (ESC), cardiac stem cells (CDC), and skeletal myoblasts.
• Critical analysis of existing research and data.

Main Results:

• Stem cell therapy has demonstrated potential in improving cardiac function and reducing infarct size in various studies.
• Different stem cell types (iPSC, ESC, CDC, skeletal myoblasts) show varying degrees of efficacy and applicability.
• Ongoing research indicates a growing capacity of stem cell populations to advance cardiac repair.

Conclusions:

• Stem cell-based therapies offer a promising avenue for treating heart disease and mitigating cardiac tissue loss.
• Further research is needed to overcome existing challenges and optimize stem cell applications for myocardial regeneration.
• Continued investigation into stem cell mechanisms and clinical translation is crucial for future therapeutic advancements.